To further evaluate the clinical significance of altered tumor levels of uPA and PAI-1 in early breast cancer, we examined the association between uPA and PAI-1 tumor tissue levels and the occurrence of the relevant events. This evidence concerns the gene SERPINE1 and breast cancer.